Health Benefits and Cost-Effectiveness of Children's Oncology Group Breast Cancer Screening Guidelines for Chest-Irradiated Hodgkin Lymphoma Survivors.
F Lennie WongJanie M LeeWendy M LeisenringJoseph P NegliaRebecca M HowellSusan A SmithKevin C OeffingerChaya S MoskowitzTara O HendersonAnn MertensPaul C NathanYutaka YasuiWendy LandierGregory T ArmstrongLeslie L RobisonSmita BhatiaPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Annual BC screening using MAM at age 30-74 years is effective and cost-effective in female chest-irradiated HL survivors. Although annual adjunct MRI is not cost-effective at $545 USD cost, it could become cost-effective as MRI cost is reduced, a plausible scenario with the emergent use of abbreviated MRI.